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Abstract
Background: Mouse preimplantation development is characterized by both active and passive
genomic demethylation. A short isoform of the prevalent maintenance DNA methyltransferase
(Dnmt1S) is found in the cytoplasm of preimplantation embryos and transiently enters the nucleus
only at the 8-cell stage.
Results: Using GFP fusions we show that both the long and short isoforms of Dnmt1 localize to
the nucleus of somatic cells and the cytoplasm of preimplantation embryos and that these
subcellular localization properties are independent of phosphorylation. Importantly,
photobleaching techniques and salt extraction revealed that Dnmt1S has a very restricted mobility
in the cytoplasm, while it is highly mobile in the nucleus of preimplantation embryos.
Conclusion: The restricted mobility of Dnmt1S limits its access to DNA and likely contributes to
passive demethylation and epigenetic reprogramming during preimplantationdevelopment.
Background
In mammals establishment and maintenance of DNA
methylation patterns are crucial for embryonic develop-
ment, cell differentiation, silencing of transposable ele-
ments, X inactivation and allele-specific expression of
imprinted genes [1]. DNA methyltransferases (Dnmts) are
responsible for establishment and maintenance of meth-
ylation patterns. In contrast to Dnmt3a and 3b, which cat-
alyze de novo methylation of unmethylated DNA, Dnmt1
shows a preference for hemi-methylated DNA and is tar-
geted to replication foci by binding to PCNA during S-
phase [2-4]. Thus, Dnmt1 is thought to maintain genomic
methylation through DNA replication by reproducing the
cytosine methylation pattern of the parental DNA strand
onto the newly synthesized strand.
Genomic methylation patterns undergo drastic changes
during gametogenesis and early embryonic development.
In the germ line, methylation patterns are erased early in
development and gamete-specific ones are established
during gametogenesis [5]. In the mouse zygote there is a
drastic decrease of DNA methylation in the paternal
genome within a few hours after fertilization (active
demethylation) and both the maternal and paternal
genomes undergo progressive demethylation during seg-
mentation stages [6-9]. This is followed by establishment
Published: 24 August 2005
BMC Developmental Biology 2005, 5:18 doi:10.1186/1471-213X-5-18
Received: 04 July 2005
Accepted: 24 August 2005
This article is available from: http://www.biomedcentral.com/1471-213X/5/18
© 2005 Grohmann et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7
(page number not for citation purposes)
BMC Developmental Biology 2005, 5:18 http://www.biomedcentral.com/1471-213X/5/18of new, tissue specific methylation patterns beginning
around the time of implantation [9,10].
Different isoforms of Dnmt1 are encoded by the mouse
dnmt1 locus. A longer isoform (Dnmt1L) is expressed in
somatic and embryonic stem cells where it is strictly
nuclear, except in post-mitotic neurons where it is also
found in the cytoplasm [2,11,12]. A shorter, maternally
contributed isoform lacking 118 amino acids at the N-ter-
minus (Dnmt1S) is found in the cytoplasm of maturing
oocytes and preimplantation embryos and enters the
nucleus only transiently at the 8-cell stage [13-16]. The
methylation maintenance function of Dnmt1 is shared by
the long and short isoforms as the latter can rescue meth-
ylation patterns and differentiation potential in ES cells
and mice lacking the former [11,17]. It is believed that
retention of Dnmt1S in the cytoplasm of preimplantation
embryos may prevent maintenance of gamete-specific
methylation patterns, determining their erasure by passive
demethylation and thus contributing to epigenetic repro-
gramming of the embryo. However, it is far from clear
how methylation patterns at imprinted loci and transpos-
able elements are maintained throughout preimplanta-
tion development and how Dnmt1S is prevented from
entering the nucleus. Interestingly, during Xenopus early
embryonic development a Dnmt1 isoform equivalent to
the mouse long isoform is present in the nuclei and only
limited demethylation occurs [18,19].
Here we investigated the localization of GFP fusions of the
long and short Dnmt1 isoforms in mouse preimplanta-
tion embryos and directly compared their mobility in the
nucleus and cytoplasm of living embryos.
Results and discussion
To directly compare the subcellular localization of the two
Dnmt1 isoforms in cycling somatic cells and preimplanta-
tion embryos we expressed GFP-fusions of Dnmt1S and L
(Fig. 1A and [4]) in both systems. After microinjection of
the expression constructs in 1-cell embryos both fusion
proteins were localized in the cytoplasm of preimplanta-
tion embryos (Fig. 1C), while they were exclusively
nuclear in transfected mouse myoblasts (Fig. 1B). These
results confirm earlier immunolocalization studies and
indicate that the differential localization of the two
Dnmt1 isoforms in somatic cells and embryos does not
depend on the additional N-terminal 118 amino acids in
Dnmt1L [13-16,20]. Nuclear localization of both iso-
forms in somatic cells is likely due to the fact that all active
nuclear localization sequences are found within the
region shared by the two Dnmt1 isoforms [15]. Indeed,
overexpression of both isoforms by injection of 2–4 fold
more plasmid DNA resulted in nuclear localisation of a
fraction of the fusion proteins also in preimplantation
embryos (Fig. 1C, 3A and 3C), suggesting a saturable cyto-
plasmic retention mechanism.
Posttranslational modification, in particular phosphor-
ylation, is a well documented mechanism controlling the
nuclear-cytoplasmic localization of a large number of pro-
teins. The only posttranslational modification reported so
far for Dnmt1 is phosphorylation of serine 514 (396 in
Dnmt1S) [21]. To test whether the phosphorylation state
Subcellular localisation of Dnmt1 isoforms in mouse somatic cells and preimplantation embryosFigure 1
Subcellular localisation of Dnmt1 isoforms in mouse 
somatic cells and preimplantation embryos. A) Sche-
matic representation of GFP-Dnmt1 fusion proteins. The 
start codons of the long (ATGL) and the short (ATGS) iso-
forms are indicated. The catalytic domain of Dnmt1 is in 
black. Subcellular localisation of GFP-Dnmt1 fusions in 
somatic cells (B) and 2-cell embryos (C). In B mouse C2C12 
myoblasts were transfected with either the GFP-Dnmt1S 
(left pair of panels) or the GFP-Dnmt1L expression con-
structs (right pair of panels) and imaged by confocal micros-
copy. The left panel in each pair shows the phase contrast 
image, while the right panel shows GFP fluorescence (scale 
bars = 5 µm). In C the same expression constructs were 
microinjected in pronuclei at the 1-cell stage and embryos 
were further cultured until the 2-cell stage (scale bars = 20 
µm). Both the short and the long isoforms of Dnmt1 are 
localised in the nucleus of myoblasts and in the cytoplasm of 
2-cell embryos. Small amounts of fusion proteins in embry-
onic nuclei (arrowheads) are due to overexpression of 
Dnmt1 and consequent saturation of the cytoplasmic reten-
tion mechanism.Page 2 of 7
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Restricted mobility of GFP-Dnmt1S in the cytoplasm of mouse preimplantation embryos. A) The GFP-Dnmt1S 
expression construct was microinjected in 1-cell stage embryos and a portion of the cytoplasm of one blastomere was 
bleached at the 2-cell stage. The upper row shows bleaching of a living embryo while the lower row shows a fixed control. 
Note that only regions immediately adjacent to the bleached area show decreased fluorescence. A very sharp bleaching bound-
ary in fixed controls shows that such decrease is not due to poor sharpness of the bleaching beam, but to diffusion of GFP-
Dnmt1S from adjacent sites. B) Salt extraction of endogenous Dnmt1S from 2-cell embryos. Soluble (S) and insoluble (P) frac-
tions were analysed by immunoblotting with an anti-Dnmt1 antibody. C) Localisation dependent mobility of Dnmt1S in 1-cell 
embryos. A square bleached area (indicated) including a small fraction of the male pronucleus (outlined) was produced in a 1-
cell embryo microinjected with the GFP-Dnmt1S construct. After bleaching no fluorescence remained in the entire pronucleus, 
while in the cytoplasm fluorescence was depleted only within and in proximity of the bleached area, indicating that the mobility 
of GFP-Dnmt1S is specifically restricted in the cytoplasm. Insets on the right show magnifications of the bleached area at the 
indicated time points. A) and C) show optical sections obtained by confocal microscopy (scale bars = 20 µm).Page 3 of 7
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Dnmt1S localisation is independent of phosphorylation. A) Schematic representation of GFP-Dnmt1S phosphorylation 
mutants. B) Western blot of transfected Cos-7 cells probed with an antibody against the N-terminal domain of Dnmt1 [25] 
showing expression of GFP-Dnmt1s wild type (wt) and phosphorylation mutants S396A and S396D with the expected molecu-
lar mass. Weak bands at 190 kDa representing endogenous Dnmt1L are indicated. C) and D) localisation of GFP-Dnmt1S 
phosphorylation mutants in mouse somatic cells and preimplantation embryos, respectively. Both mutant proteins localise to 
the nucleus of somatic cells and to the cytoplasm of preimplantation embryos like wild type GFP-Dnmt1S (Fig. 1B and C). In D 
embryos were fixed and immunostained with an anti-GFP antibody detected with a red fluorescent secondary antibody. The 
upper row shows GFP fluorescence and the lower row shows the immunofluorescent signal (IF). The IF gradient from the 
periphery to the centre of some embryos is an optical artefact depending on signal intensity [15].Page 4 of 7
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GFP-Dnmt1S we generated mutations either mimicking
the phosphorylated state (S396D) or preventing it
(S396A; Fig. 2A). As shown in figure 2C and 2D neither
mutation changed the nuclear localization of GFP-
Dnmt1S in somatic cells or the cytoplasmic localization in
preimplantation embryos.
To further investigate whether GFP-Dnmt1S is soluble or
tightly bound to cytoplasmic structures in preimplanta-
tion embryos we tested fluorescence recovery after pho-
tobleaching of a defined region in the cytoplasm of
microinjected embryos (Fig. 3A). Fluorescence recovery
was very slow in living embryos with very little decrease of
fluorescence in the non-bleached regions apart for those
just next to the bleached area. This slow recovery could be
explained by repeated association with fixed binding sites
restricting its diffusion in the cytoplasm. We further
assayed the stability of such binding of the endogenous
Dnmt1S by salt extraction experiments (Fig. 3B). Essen-
tially all Dnmt1S was found in the insoluble fraction with
up to 250 mM NaCl, but was solubilized at 400 mM. This
result provides biochemical evidence for strong interac-
tions of Dnmt1S in early embryos. Since Dnmt1 is highly
mobile in nuclei of somatic cells (data not shown) we
directly compared the mobility of the short Dnmt1 iso-
form in the cytoplasm to that in the nucleus of the same
embryo. For this we extensively bleached a region span-
ning across the nuclear-cytoplasmic boundary (Fig. 3C).
Although only about one tenth of the nuclear volume was
illuminated, the nuclear fluorescence was entirely
depleted, indicating a high mobility of GFP-Dnmt1S mol-
ecules in the nucleus. In contrast, only regions within and
close to the targeted area in the cytoplasm showed
decreased fluorescence. As above, the rate of fluorescence
recovery was slow, which is consistent with Dnmt1S bind-
ing to fixed structures in the cytoplasm. These results
clearly show that Dnmt1S has a much higher mobility in
the nucleus than in the cytoplasm of preimplantation
embryos.
In summary, the subcellular localization of Dnmt1 does
not depend on either the additional 118 amino acids at
the N-terminus of Dnmt1L or the phosphorylation state at
serine 396 of Dnmt1S. Previously, we showed that
Dnmt1S fused to a SV40 NLS was still retained in the cyto-
plasm, ruling out that masking of the NLS of Dnmt1S
could be the mechanism preventing nuclear localization
like in the case of IκB preventing nuclear import of NF-κB.
The biochemical extraction data indicate a strong binding
of Dnmt1S, the overexpression experiments show that
these binding sites are saturable and the fluorescence
bleaching results demonstrate that GFP-Dnmt1S is specif-
ically immobilized in the cytoplasm of preimplantation
embryos.
Conclusion
Taken together the data presented in this study argue for a
strong binding of Dnmt1S to immobile structures in the
cytoplasm of early embryos. Sequestration of Dnmt1 in
the cytoplasm of embryos is likely to prevent full mainte-
nance of methylation patterns during preimplantation
development. Since mice expressing reduced levels of
Dnmt1 protein already show severe genomic hypometh-
ylation [22], even partial cytoplasmic retention of Dnmt1
could account for global passive demethylation and epi-
genetic reprogramming. At the same time, preferential tar-
geting of remaining nuclear Dnmt1 could allow
maintenance of parental methylation patterns at
imprinted loci and silencing of endogenous retroviral
elements.
Methods
DNA constructs
The expression construct for GFP-Dnmt1S (pEGMT1S)
was derived by subcloning the cDNA insert from pEMT
[23] into the Kpn I / Xma I site of the pEGFP-C1 vector
(Clontech). The mutations S396D and S396A were intro-
duced in pEMT by site directed mutagenesis using the
QuikChange system (Stratagene) and the corresponding
cDNA inserts were subcloned into the pEGFP-C1 vector as
above. The expression construct for GFP-Dnmt1L
(pEGMT1L) was obtained in two steps. First a 3.3 kb Xma
I fragment from a PCR product spanning the whole N-ter-
minal regulatory domain of Dnmt1L was cloned in the
pEGFP-C1 vector to obtain pEGNMT. Next a Hind III /
Psh AI fragment of pEGMT1S encompassing part of the
EGFP coding sequence and the 5' part of the partial
Dnmt1 cDNA till shortly downstream of ATG4 [11] was
replaced with the corresponding fragment from pEGNMT,
which contains the complete 5' sequence of Dnmt1L
cDNA, including the part encoding the additional 118
amino acids. In all vectors transcription is under the con-
trol of the CMV promoter.
Embryo collection, culture, microinjection and cell 
transfection
Mouse embryos were obtained from FVB/N superovu-
lated females mated with FVB/N males. For superovula-
tion females (3–4 weeks old) were injected
intraperitoneally with 5 IU of pregnant mare serum (PMS)
followed by intraperitoneal injection of 5 IU of human
chorionic gonadotropin (hCG) 46–48 hours later. Mat-
ings were set up right after hCG injection. Zygotes were
collected from the oviduct of 0.5 days post-coitum (d.p.c.)
donors into M2 medium containing 300 µg/ml hyaluro-
nidase to remove the cumulus cells. After washing in M2
medium the zygotes were transferred to M16 medium in
microdrop cultures for further development up to the
blastocyst stage in a humidified 5% CO2 incubator at
37°C. Culture conditions and media compositions werePage 5 of 7
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ized, purified with standard glassmilk absorption tech-
niques (Qiagen) and resuspended in microinjection
buffer (8 mM Tris, pH 7.4 and 0.15 mM EDTA) at a final
concentration of 10 µg/ml. DNA was injected into male
pronuclei. C2C12 mouse myoblasts and Cos-7 cells were
cultured and transfected as described [4,15].
Immunofluorescence
Embryos were fixed with 3.7% formaldehyde in PBS for
10 min, permeabilised with 0.25% Triton X-100 in PBS
and blocked with 0.2% fish skin gelatine in PBS for 30
min. Both primary and secondary antibodies were diluted
in blocking solution and applied for 1 hr. The rabbit pol-
yclonal antibody to GFP was from Abcam and was
detected with an anti-rabbit secondary antibody conju-
gated with Alexa Fluor 568 (Molecular Probes). Embryos
were washed with 0.1% NP-40 in PBS and mounted in
Mowiol.
Confocal Microscopy and Fluorescence Recovery after 
Photobleaching (FRAP)
Confocal images (2 µm thick optical slices) were taken
with a confocal laser scanning microscope LSM510
(Zeiss) using a 488 nm and a 543 nm laser lines for GFP
and Alexa Fluor 568 excitation and BP 500–530 nm and
LP 570 nm filters for detection, respectively. For live cell
microscopy, microinjected embryos were transferred to 8-
well LabTek chambers (Nunc) containing M2 medium.
FRAP experiments were performed at RT on a LSM510
using a 63 × Plan-Apochromat oil immersion objective
(N.A. 1.4; Zeiss) with a 488 nm argon laser line. After
acquisition of an initial (prebleach) optical section, a
selected area was bleached for up to 30 s at 100 % laser
power. Fluorescence recovery was then monitored by time
lapse imaging 2 s and 5, 10 and 15 min after bleaching at
low laser power.
Salt extraction of mouse embryos
2-cell stage embryos were washed in PBS and transferred
to a fresh Eppendorf tube in a 10 µl volume. 10 µl of 2 ×
EBC lysis buffer (100 mM Tris-HCl pH 8,0; 1% NP-40,
pepstatin, aprotinin, leupeptin 2 µg/ml each, 200 µg/ml
PMSF and either 200 mM, 500 mM or 800 mM NaCl)
were added to each sample, followed by 5 min incubation
on ice. 45 embryos were processed in each case. After cen-
trifugation at 13,000 rpm and 4°C for 5 min soluble
(supernatant) and insoluble (pellet) fractions were ana-
lysed by SDS-PAGE followed by immunoblotting and
incubation with an antibody against the N-terminal
domain of Dnmt1 [25].
Abbreviations
GFP: green fluorescent protein; Dnmt: DNA
methyltransferase.
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